Aug 10, 2023 8:00am EDT Artelo Biosciences Reports Second Quarter 2023 Financial Results and Provides Business Update
Jul 19, 2023 9:00am EDT Artelo Biosciences to Present New Mechanism of Action Data on ART26.12 at the Gordon Research Conference on July 20, 2023
Jul 10, 2023 8:30am EDT Artelo Biosciences CEO to Participate in the Benzinga All Access Event on July 11
Jun 28, 2023 8:30am EDT Artelo Biosciences Announces Sponsorship of The William A. Devane Early Career Investigator Award at the 33rd Annual International Cannabinoid Research Society Symposium
Jun 27, 2023 8:30am EDT Artelo Biosciences Announces Important New Data on ART26.12 Demonstrating Positive Effects in Multiple Models of Neuropathic Pain at the 33rd Annual International Cannabinoid Research Society Symposium
Jun 26, 2023 8:30am EDT Artelo Biosciences Reports Superior Preclinical Pharmaceutical Properties and Efficacy of ART12.11 Compared to Cannabidiol (CBD) at the 33rd Annual International Cannabinoid Research Society Symposium
Jun 07, 2023 8:30am EDT Artelo Biosciences Selected for Oral Presentation to Report Positive Research Findings on ART12.11 at the 33rd Annual International Cannabinoid Research Society Symposium
May 11, 2023 8:00am EDT Artelo Biosciences Reports First Quarter 2023 Financial Results and Provides Business Update
Apr 25, 2023 8:30am EDT Artelo Biosciences Initiates the Phase 2a Portion of its CAReS Trial EvaluatingART27.13 for the Treatment of Cancer-Related Anorexia and Weight Loss
Mar 31, 2023 8:00am EDT Artelo Biosciences Reports Fiscal 2022 Year-End Financial Results and Provides Business Update
